Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

This risk minimisation material is for Apixaban Krka tablets for all indications. Please ensure that you are familiar with this material before prescribing Apixaban Krka as it contains important safety information on the potential risk of bleeding during treatment with Apixaban and provides guidance on how to manage that risk. If you would like to obtain hard copies of the Apixaban Krka 2.5mg & 5mg Prescriber Guide and/or Patient Alert Card and/or SPCs, please contact Krka UK Limited (Email: [email protected], phone: +44 (0) 207 164 6156). Risk minimisation materials can only be delivered to UK registered healthcare premises.